Literature DB >> 14578301

Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits.

Roberto Lorusso1, Samuele Pentiricci, Riccardo Raddino, Tiziano M Scarabelli, Claudia Zambelli, Vincenzo Villanacci, Anna Burattin, Giuseppe Romanelli, Salvatore Casari, Roberto Scelsi, Andrea Giustina.   

Abstract

Recent studies have reported a high incidence of postoperative unfavorable cardiac-related events in patients with diabetes who underwent coronary artery bypass grafting (CABG). Structural and functional characteristics of CABG conduits, which have been shown to play an important role in patient outcome after myocardial revascularization, have not been fully investigated in diabetic subjects. Therefore, we sought to determine the influence of adult-onset diabetes on vasoreactivity and morphological profile of venous and arterial grafts. Of the 160 consecutive patients enrolled in the study, 90 were diagnosed with type 2 diabetes and 70 did not have diabetes (control group). All patients underwent evaluation of glucose control before surgery. Tissue specimens were collected from left internal thoracic artery (LITA) and saphenous vein (SV) grafts harvested during elective CABG. Functional tests were performed to assess contractile and vasodilative responses of bypass conduits. Histological evaluation was carried out to examine vessel wall structure. Univariate and multivariate analyses were performed to correlate the preoperative factors related to the control of the endocrine disorder with histological findings. Patient medical history and demographics did not differ between the groups. Diabetic patients showed significant microalbuminuria and higher plasma levels of C-peptide and GHb as compared with nondiabetic subjects. Functional tests of the LITA segments revealed no difference between groups with regard to contractile and vasodilative responses. In contrast, significant impairment in the endothelium-related vasodilation of the SV grafts was observed in diabetic subjects. Histological studies showed structural preservation of the arterial conduits in both groups. However, marked intimal abnormalities (also atherosclerotic calcified plaques) were detected in SV grafts harvested from diabetic patients. Logistic regression analysis showed that high levels of proteinuria and GHb were independent predictors of advanced structural degeneration of SV conduits. Treatment modality, duration of diabetes, and other demographic or metabolic factors were found to have no influence on the morphological characteristics of SV conduits. In conclusion, biological properties of LITA conduits for CABG were preserved in diabetic patients. However, these patients frequently showed impairment of the endothelium-dependent vasorelaxation and intimal degeneration of SV grafts. The extent of structural abnormalities of SV grafts was inversely correlated with the efficacy of the metabolic control of the endocrine disorder. Further studies are required to conclusively correlate preoperative SV graft abnormalities with postoperative conduit patency rate and the occurrence of adverse cardiac-related events in diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578301     DOI: 10.2337/diabetes.52.11.2814

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Functional differences between healthy and diabetic endothelial cells on topographical cues.

Authors:  Marie F A Cutiongco; Bryan M X Chua; Dawn J H Neo; Muhammad Rizwan; Evelyn K F Yim
Journal:  Biomaterials       Date:  2017-10-25       Impact factor: 12.479

2.  Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Gabriele Pelissero; Sebastiano Bruno Solerte; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Adriana Garzaniti; Andrea Giustina
Journal:  Intern Emerg Med       Date:  2011-02-05       Impact factor: 3.397

3.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

4.  Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake.

Authors:  Rajkumar Pyla; Prahalathan Pichavaram; Arwa Fairaq; Mary Anne Park; Mark Kozak; Vinayak Kamath; Vijay S Patel; Lakshman Segar
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

5.  Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.

Authors:  Kirsten Riches; Aliah R Alshanwani; Philip Warburton; David J O'Regan; Stephen G Ball; Ian C Wood; Neil A Turner; Karen E Porter
Journal:  J Mol Cell Cardiol       Date:  2014-06-10       Impact factor: 5.000

6.  Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis.

Authors:  Suning Ping; Yuhuang Li; Shuying Liu; Zhengyu Zhang; Jingjing Wang; Yuhuan Zhou; Kefeng Liu; Jintao Huang; Dadi Chen; Junmei Wang; Chaohong Li
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

7.  Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction.

Authors:  Albino Carrizzo; Carmine Vecchione; Antonio Damato; Flavio di Nonno; Mariateresa Ambrosio; Franco Pompeo; Enrico Cappello; Luca Capocci; Mariangela Peruzzi; Valentina Valenti; Giuseppe Biondi-Zoccai; Antonino G M Marullo; Silvia Palmerio; Roberto Carnevale; Chiara C Spinelli; Annibale A Puca; Speranza Rubattu; Massimo Volpe; Junichi Sadoshima; Giacomo Frati; Sebastiano Sciarretta
Journal:  J Am Heart Assoc       Date:  2017-02-28       Impact factor: 5.501

Review 8.  Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus.

Authors:  Florah Tshepo Moshapa; Kirsten Riches-Suman; Timothy Martin Palmer
Journal:  Cardiol Res Pract       Date:  2019-01-02       Impact factor: 1.866

9.  Comparison of endothelial function of coronary artery bypass grafts in diabetic and nondiabetic patients: Which graft offers the best?

Authors:  Demet Özkaramanlı Gür; Özcan Gür; Selami Gürkan; Selcem Cömez; Aylin Gönültaş; Murat Yılmaz
Journal:  Anatol J Cardiol       Date:  2015-08       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.